Skip to main content
Latest News
September 25, 2026
Bristol Myers Squibb Announces First Presentation of Results for ZENBEXUS™ (iberdomide) in Combination with Daratumumab from Phase 3 EXCALIBER-RRMM Trial in Relapsed or Refractory Multiple Myeloma
September 18, 2026
Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026
September 17, 2026
Bristol Myers Squibb Presents Sotyktu (deucravacitinib) Data Showing Durable Efficacy, Consistent Safety in Adults with Psoriatic Arthritis Over Two Years
Latest Events
Event year list
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
October 29, 2026
08:00 AM ET
Bristol Myers Squibb Q3 2026 Results Conference Call
Webcast
(opens in new window)
July 30, 2026
08:15 AM ET
Bristol Myers Squibb Q2 2026 Results Conference Call
Webcast
(opens in new window)
Press Release (PDF)
Quarterly Package of Financial Information (XLS)
Q2 2026 Results Presentation (PDF)
Q2 2026 Results Presentation (with Appendix) (PDF)
Preliminary Q2 2026 Acquired IPRD & Licensing Income (PDF)
June 9, 2026
02:00 PM EST
Goldman Sachs 47th Annual Global Healthcare Conference
Webcast
(opens in new window)